Novo wants to share ownership eventually
If the IPO of NNIT should become a reality, the most likely scenario is that Novo will sell existing shares rather than issue new ones, says CFO Jesper Brandgaard. But he says there are strategic issues to consider as well.
by Stefan Singh Kailay
Novo Nordisk will probably account for less than half of the revenue in subsidiary NNIT at the end of this year, and according to Jesper Brandgaard, CFO in Novo Nordisk and Chairman of the Board in NNIT, that is the reason why the Danish diabetes giant is looking at the options for sharing ownership of its subsidiary with someone else.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Novo company considers going public
For abonnenter
Novo Nordisk-director quits the company
For abonnenter
